Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MG-COVID: Hydroxychloroquine and Azithromycin in Early COVID-19
NCT04371406Phase 3Withdrawn
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of hydroxychloroquine, azithromycin in coronavirus disease 2019 (COVID-19), sponsored by Assistance publique - Hôpitaux de Paris. Planned start Apr 2020; status: withdrawn.
02
Drugs
hydroxychloroquineazithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04371406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04371406.